NLS Pharmaceutics's total assets for Q were $9.28M, an increase of 350.75% from the previous quarter. NLSP total liabilities were $6.00M for the fiscal quarter, a -1.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.